Could adding common diabetes pills improve type 1 control?

NCT ID NCT07676565

Recruiting now Disease control Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study looks at whether adding GLP-1 receptor agonists or SGLT inhibitors to insulin helps adults with type 1 diabetes manage their blood sugar better. Researchers will track 300 participants for one year, measuring changes in HbA1c and other health markers. The goal is to see if these add-on therapies are safe and effective when used in everyday care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GLP-1RA and SGLTi drugs (as add-ons to insulin)
What this could lead to: If successful, this could show that adding these drugs to insulin improves blood sugar control and reduces complications for people with type 1 diabetes.
What could go wrong: This is an observational registry study, not a controlled trial, so results may be less definitive. The drugs are already used off-label, and benefits or risks may vary widely among participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Emory University
RECRUITING

Atlanta, Georgia, 30303, United States
Harvard Medical School
RECRUITING

Boston, Massachusetts, 02115, United States
Henry Ford Hospital
RECRUITING

Detroit, Michigan, 48202, United States
Hoag Memorial Hospital
RECRUITING

Newport Beach, California, 92663, United States
Maine Health Research Institute
RECRUITING

Portland, Maine, 04102, United States
Mount Sinai
RECRUITING

New York, New York, 10029, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.